News

I’m an oncologist and have seen a startling rise in the incidence of colorectal cancer rise among younger adults.
Every country should have a strategy for tackling prostate cancer with dedicated screening programs for men over 50, a ...
I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother's new doctor ...
Men’s health has been neglected for far too long with devastating consequences. Globally, men’s life expectancy lags five ...
Every country in the world should have a strategy for tackling prostate cancer, with dedicated nationwide screening programs ...
Your diet has an important role to play in reducing your risk of cancer. To safeguard your health, you may want to consider ...
Adding CAN-2409 to standard radiation therapy significantly improved disease-free survival and pathological complete response ...
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a New Frontiers in Prostate-Specific Membrane ...
Dr. Angela Jia discussed How Better Treatments and Better Selection Can Improve Patient Outcomes in Localized Prostate Cancer. Dr. Jia discussed two important abstracts presented during the session: ...
The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic ...
According to J&J, Akeega is the first PARP inhibitor combination that’s proven effective treating earlier-stage prostate ...
Johnson & Johnson (JNJ) posts Phase 3 trial win for Akkega plus prednisone in metastatic castration-sensitive prostate cancer ...